[1]Kim HH, Jo MK, Kwak C, et al. Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea[J]. Urology, 2002, 59:517-521. [2]Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study[J]. BJU Int, 2017, 120: 109-116. [3]Scales CD, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States[J]. Eur Urol, 2012, 62:160-165. [4]Yasui T, Iguchi M, Suzuki S, et al. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005[J]. Urology, 2008, 71:209-213. [5]Skolarikos A, Straub M, Knoll T, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines[J]. Eur Urol, 2015, 67:750-763. [6]东洁,张寅生,郭正光,等. 液相色谱-质谱串联技术在尿液枸橼酸含量测定中的应用[J]. 中华医学杂志, 2017, 97: 3471-3474. [7]东洁,张寅生,郭正光,等. 液相色谱-质谱串联技术定量测定尿中草酸含量的意义[J]. 中华医学杂志, 2017, 97: 2043-2046. [8]张学斌,李汉忠,孙昊,等. 双源CT体内预测尿路结石成分的临床应用研究(附40例报告)[J]. 临床泌尿外科杂志, 2014, 29: 93-96. [9]张古沐阳,石冰,薛华丹,等. 双源双能量CT前瞻性分析体内泌尿系结石的主要成分[J]. 放射学实践, 2018, 33: 55-59. [10]Spivacow FR, Del Valle EE, Lores E, et al. Kidney stones: composition, frequency and relation to metabolic diagnosis[J]. Medicina (B Aires), 2016,76:343-348. |